The CEO of Intrexon (NASDAQ: XON) is Buying Shares

By Carrie Williams

Today, the CEO of Intrexon (XONResearch Report), Randal Kirk, bought shares of XON for $3.69M.

Following this transaction Randal Kirk’s holding in the company was increased by 1.78% to a total of $217 million.

See today’s analyst top recommended stocks >>

Currently, Intrexon has an average volume of 2.87M.

The insider sentiment on Intrexon has been neutral according to 56 insider trades in the past three months. This sentiment is higher than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Intrexon Corp. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals.